Xencor INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
Vanguard Capital Management has reported a beneficial ownership of 5.13% in Xencor Inc., holding 3,810,823 shares as of June 30, 2026.
NASDAQ
EcoR1 Capital, LLC and Oleg Nodelman have filed a Schedule 13G reporting a 2.9% beneficial ownership stake in Xencor Inc.
NASDAQ
RA Capital Management and its affiliates have reported a 6.5% beneficial ownership stake in Xencor, Inc., totaling 4,736,739 shares of common stock.
NASDAQ
The Vanguard Group has reported 0% beneficial ownership in Xencor Inc. following an internal realignment that shifts reporting to its subsidiaries.
NASDAQ
State Street Corporation has reported a 6.3% beneficial ownership stake in Xencor Inc. common stock as of December 31, 2025.
NASDAQ
The Vanguard Group has reported an increased beneficial ownership of Xencor Inc. common stock, now holding 10.03% of the class.
NASDAQ
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting a 2.4% beneficial ownership stake in Xencor Inc. as of September 30, 2025.
NASDAQ
RTW Investments, LP and Roderick Wong, M.D. have disclosed a beneficial ownership of 8.7% in Xencor Inc.'s common stock.
NASDAQ
The Vanguard Group has increased its beneficial ownership in Xencor Inc. to 9.95% of common stock, holding over 7.1 million shares.
NASDAQ
Biotechnology Value Fund and its affiliates, including Mark N. Lampert, have disclosed a collective beneficial ownership of 6.5% in Xencor Inc. common stock.
NASDAQ
PRIMECAP Management Co. reports an increased passive stake of 14.79% in Xencor, Inc., holding over 10.5 million shares.
NASDAQ
The Vanguard Group has reported a 12.11% beneficial ownership stake in Xencor Inc, held for passive investment purposes.
NASDAQ
State Street Corporation has filed a Schedule 13G, revealing a 5.2% beneficial ownership stake in Xencor Inc. as of March 31, 2025.
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.8% beneficial ownership stake in Xencor Inc. as of March 31, 2025.
NASDAQ
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 17.4% beneficial ownership in Xencor Inc.'s common stock as of December 31, 2024.